Following a data breach and bankruptcy, genetic testing service 23andMe will soon be in different hands. On Monday, biotechnology company Regeneron announced that it won the top bid in a bankruptcy ...
Hosted on MSN
‘Would you post your DNA on Facebook?’ Why I’d never use 23andMe or any other DNA testing service
You’re worth a fortune. I was sorry that 23andMe filed for Chapter 11 bankruptcy protection last week, but there would be a blizzard in Death Valley before I would ever use an online DNA kit company.
23andMe is teetering on the edge of bankruptcy and actively seeking a buyer. That buyer, unless explicitly restricted, could gain access to the sensitive genetic data of more than 14 million people.
A 2023 data breach hurt demand for 23andMe's core services Transaction is expected to complete in the third quarter May 19 (Reuters) - (Corrects to say the company filed for bankruptcy in March, not ...
Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million. The ...
A bankruptcy judge has approved the sale of the insolvent genetics firm 23andMe to a nonprofit run by one of the company's co-founders. The deal effectively avoids the controversial transfer of DNA ...
At a court hearing in St. Louis, Mo. yesterday (June 4), 23andMe’s attorney inadvertently revealed that Wojcicki’s post-auction proposal had reached $305 million. Wojcicki, who resigned as 23andMe’s ...
Your DNA results are in — and they’re 100 percent the property of a pharmaceutical manufacturer. Put simply, the genetic information of millions is now in the hands of a drugmaker seeking to mine it ...
Genetic testing company 23andMe never hit on a sustainable business model and went bankrupt. Now, it's being sold to a non-profit launched by the co-founder, delaying addressing data privacy concerns.
Gadget Review on MSN
23andMe breach victims to split $46.75 million settlement
23andMe's $46.75 million breach settlement splits roughly $6 to $7 per person among 6.9 million victims whose genetic data ...
23andMe and its co-founder, Anne Wojcicki, aimed to revolutionize healthcare. Earlier this year, WSJ took a look at factors that knocked the company’s valuation down to nearly $0. Photo: Peter DaSilva ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results